Many studies have shown that the NF-κB signaling pathway plays an important role in the drug resistance of tumor cells and many chemotherapeutic drugs and radiotherapy induce NF-κB expression in vitro and in vivo [29]. The gene discussed is NFKB1; the disease is neoplasm.